Literature DB >> 19887955

Relation of circulating markers of fibrosis and progression of left and right ventricular dysfunction in hypertensive patients with heart failure.

Rafal Plaksej1, Wojciech Kosmala, Stefan Frantz, Sebastian Herrmann, Markus Niemann, Stefan Störk, Rolf Wachter, Christiane E Angermann, Georg Ertl, Bart Bijnens, Frank Weidemann.   

Abstract

OBJECTIVE: To study the association of circulating markers of fibrosis: procollagen type III amino-terminal propeptide (PIIINP), procollagen type I carboxy-terminal propeptide (PIP) and collagen type I carboxy-terminal telopeptide (CITP): with left (LV) and right ventricular (RV) longitudinal and LV radial systolic function in patients with heart failure in the course of essential hypertension.
METHODS: The study population consisted of 81 patients with hypertension divided into four groups according to NYHA classification and 20 healthy controls. Cardiac function was estimated by myocardial deformation indices assessed by tissue Doppler imaging. Serum PIIINP, PIP and CITP levels were quantified by radioimmunoassay.
RESULTS: Progressive LV longitudinal function impairment was demonstrated in all hypertension groups as indicated by reduced peak systolic strain and strain rate and increased postsystolic strain index. The respective indicators of LV radial function were deteriorated only in NYHA classes III-IV. Concurrently, RV longitudinal function was found abnormal in NYHA classes II-IV. PIIINP concentration was higher in NYHA class III and IV, whereas CITP level was increased and PIP/CITP ratio was decreased in the NYHA IV individuals. PIIINP was an independent correlate of LV and RV longitudinal strain (R = 0.52, beta = -0.34, P < 0.001; R = 0.25, beta = -0.27, P < 0.01, respectively). PIP/CITP ratio independently determined LV radial strain in patients with LV ejection fraction less than 50% (R = 0.44, beta = 0.52, P < 0.008).
CONCLUSION: In hypertensive patients, the progressive decline in cardiac longitudinal function is related to increased collagen III synthesis, whereas the changes in collagen I turnover favoring its increased degradation might contribute to LV radial and global systolic dysfunction seen in the advanced hypertensive heart disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19887955     DOI: 10.1097/HJH.0b013e3283316c4d

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  18 in total

1.  Biological variation of extracellular matrix biomarkers in patients with stable chronic heart failure.

Authors:  Tobias Täger; Clara Wiebalck; Hanna Fröhlich; Anna Corletto; Hugo A Katus; Lutz Frankenstein
Journal:  Clin Res Cardiol       Date:  2017-08-04       Impact factor: 5.460

2.  Pharmacological inhibition of βIIPKC is cardioprotective in late-stage hypertrophy.

Authors:  Julio C B Ferreira; Tomoyoshi Koyanagi; Suresh S Palaniyandi; Giovanni Fajardo; Eric N Churchill; Grant Budas; Marie-Helene Disatnik; Daniel Bernstein; Patricia C Brum; Daria Mochly-Rosen
Journal:  J Mol Cell Cardiol       Date:  2011-09-02       Impact factor: 5.000

3.  The relationship between serum markers of collagen turnover and cardiovascular outcome in the elderly: the Cardiovascular Health Study.

Authors:  Eddy Barasch; John S Gottdiener; Gerard Aurigemma; Dalane W Kitzman; Jing Han; Willem J Kop; Russell P Tracy
Journal:  Circ Heart Fail       Date:  2011-09-07       Impact factor: 8.790

Review 4.  [The various forms of left ventricular hypertrophy: diagnostic value of echocardiography].

Authors:  F Weidemann; S Störk; S Herrmann; G Ertl; M Niemann
Journal:  Herz       Date:  2011-12       Impact factor: 1.443

5.  Increased extracellular volume and altered mechanics are associated with LVH in hypertensive heart disease, not hypertension alone.

Authors:  Sujith Kuruvilla; Rajesh Janardhanan; Patrick Antkowiak; Ellen C Keeley; Nebiyu Adenaw; Jeremy Brooks; Frederick H Epstein; Christopher M Kramer; Michael Salerno
Journal:  JACC Cardiovasc Imaging       Date:  2015-01-07

Review 6.  Systemic sclerosis and the heart: current diagnosis and management.

Authors:  Chintan S Desai; Daniel C Lee; Sanjiv J Shah
Journal:  Curr Opin Rheumatol       Date:  2011-11       Impact factor: 5.006

7.  Detection of Myocardial Fibrosis and Left Ventricular Dysfunction with Cardiac MRI in a Hypertensive Swine Model.

Authors:  Baiyan Zhuang; Chen Cui; Arlene Sirajuddin; Jian He; Xin Wang; Guangxin Yue; Xuejing Duan; Hongyue Wang; Andrew E Arai; Shihua Zhao; Minjie Lu
Journal:  Radiol Cardiothorac Imaging       Date:  2020-08-27

8.  Incident heart failure in relation to vascular disease: insights from the Health, Aging, and Body Composition Study.

Authors:  Hassan Khan; Andreas P Kalogeropoulos; Faiez Zannad; Catherine N Marti; Peter W F Wilson; Vasiliki V Georgiopoulou; Alka M Kanaya; Anne B Newman; Erik Schelbert; Tamara B Harris; Stephen Kritchevsky; Clyde Yancy; Mihai Gheorghiade; Gregg C Fonarow; Javed Butler
Journal:  Eur J Heart Fail       Date:  2014-02-27       Impact factor: 15.534

Review 9.  Understanding cardiac extracellular matrix remodeling to develop biomarkers of myocardial infarction outcomes.

Authors:  Signe Holm Nielsen; Alan J Mouton; Kristine Y DeLeon-Pennell; Federica Genovese; Morten Karsdal; Merry L Lindsey
Journal:  Matrix Biol       Date:  2017-12-14       Impact factor: 11.583

10.  Modest elevation in BNP in asymptomatic hypertensive patients reflects sub-clinical cardiac remodeling, inflammation and extracellular matrix changes.

Authors:  Dermot Phelan; Chris Watson; Ramon Martos; Patrick Collier; Anil Patle; Seamas Donnelly; Mark Ledwidge; John Baugh; Ken McDonald
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.